New Daily COVID-19 Cases Return to 400s...Cumulative Vaccine Doses Surpass 700,000 (Update)

411 Local Cases, 17 Imported Cases
20,151 Additional First Dose Vaccinations
1 More Suspected Anaphylaxis Case Reported

On the 22nd, citizens are waiting to get tested at the temporary COVID-19 screening clinic set up at Seoul Station Plaza. Photo by Mun Ho-nam munonam@

[Asia Economy Reporter Kim Ji-hee] On the 24th, the number of new domestic COVID-19 cases recorded 428, returning to the 400s after a day.

The Central Disease Control Headquarters (CDCH) announced that as of midnight on that day, 428 new domestic COVID-19 cases were confirmed, bringing the total to 99,846. Regarding the infection routes, 411 cases were locally transmitted, and 17 were imported cases.

On this day as well, more than 300 cases were reported in the metropolitan area, including Seoul, Gyeonggi, and Incheon. In Seoul, 135 cases were confirmed, with 150 in Gyeonggi and 21 in Incheon. In non-metropolitan areas, cases were reported as follows: 27 in Gyeongnam, 18 in Gangwon, 17 in Daegu, 16 in Busan, 12 in Gyeongbuk, 6 in Chungbuk, 4 in Jeonbuk, 2 each in Gwangju and Daejeon, and 1 in Ulsan. There were no additional cases reported in four regions: Sejong, Chungnam, Jeonnam, and Jeju.

The cumulative number of COVID-19 deaths increased by 3 from the previous day, reaching 1,707. The number of critically ill patients increased by 10 to 111. The number of patients who were declared recovered and released from isolation increased by 481 to 91,560.

With the weekend effect over, the total number of tests on this day exceeded 70,000. The number of diagnostic tests for suspected cases was 40,220. At temporary screening clinics set up in the metropolitan area, 31,774 tests were conducted, confirming 54 positive cases.

Meanwhile, the COVID-19 Vaccination Response Promotion Team reported that as of midnight on this day, 20,151 people received their first dose, bringing the cumulative total of first-dose recipients to 703,612. The vaccination rate stands at 57.7%. Among them, 643,724 received the AstraZeneca vaccine, and 59,888 received the Pfizer vaccine.

The number of suspected adverse reactions reported after COVID-19 vaccination increased by 128 from the previous day, totaling 9,932 cases. Among the newly reported adverse reactions, one case was suspected anaphylaxis, and the rest were mild.

This content was produced with the assistance of AI translation services.